Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF

被引:33
|
作者
Funaoka, K
Shindoh, M
Yoshida, K
Hanzawa, M
Hida, K
Nishikata, S
Totsuka, Y
Fujinaga, K
机构
[1] HOKKAIDO UNIV, SCH DENT, DEPT ORAL PATHOL, KITA KU, SAPPORO, HOKKAIDO 060, JAPAN
[2] HOKKAIDO UNIV, SCH DENT, DEPT ORAL SURG 2, SAPPORO, HOKKAIDO 060, JAPAN
[3] SAPPORO MED UNIV, SCH MED, CANC RES INST, DEPT BIOL MOL, SAPPORO, HOKKAIDO 060, JAPAN
关键词
D O I
10.1006/bbrc.1997.6909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p21(Waf1/Cip1) is one of the key regulatory proteins in cell cycle, terminal differentiation, and apoptosis. Its promoter was shown to be transactivated by the wild-type p53 protein as well as in a p53-independent manner. In this report, we demonstrate that E1AF, an ets-related transcription factor, activated the human p21(Waf1/Cip1) promoter by interacting with the ets-binding sites located close to the two previously identified p53-responsive elements. Northern blot analysis revealed that p21(Waf1/Cip1) and E1AF were correlatively upregulated in response to cisplatin treatment in SiHa cells. Transient expression assays demonstrated that E1AF can activate the p21(Waf1/Cip1) promoter-driven luciferase reporter gene in SiHa cells. The p21(Waf1/Cip1) promoter activity was also increased in p53-null Saos2 osteosarcoma cells, but was markedly reduced when the ets-binding sites were deleted. These results indicate that E1AF positively regulates transcription from the p21(Waf1/Cip1) promoter in response to genotoxic stresses. (C) 1997 Academic Press.
引用
收藏
页码:79 / 82
页数:4
相关论文
共 50 条
  • [31] ANKHD1 represses p21 (WAF1/CIP1) promoter and promotes multiple myeloma cell growth
    Dhyani, Anamika
    Machado-Neto, Joao A.
    Favaro, Patricia
    Olalla Saad, Sara T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (02) : 252 - 259
  • [32] Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3
    Gartel, AL
    Ye, X
    Goufman, E
    Shianov, P
    Hay, N
    Najmabadi, F
    Tyner, AL
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (08) : 4510 - 4515
  • [33] Growth factor modulation of p21(WAF1/CIP1) in primary acute myeloid leukemias.
    DiGiuseppe, JA
    Gore, SD
    Weng, LJ
    Kastan, MB
    BLOOD, 1996, 88 (10) : 331 - 331
  • [34] FUNCTIONAL-ANALYSIS OF THE TRANSFORMING GROWTH-FACTOR-BETA RESPONSIVE ELEMENTS IN THE WAF1/CIP1/P21 PROMOTER
    DATTO, MB
    YU, Y
    WANG, XF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) : 28623 - 28628
  • [35] P21 CIP1/WAF1/SDI1与细胞增殖调控
    周剑涛
    徐久元
    九江医学, 1999, (04) : 250 - 253
  • [36] A somatic mutation of the p21((Waf1/Cip1)) gene in a human adrenocortical adenoma
    Iida, S
    Fujii, H
    Moriwaki, K
    ANTICANCER RESEARCH, 1997, 17 (1B) : 633 - 636
  • [37] p21(WAF1/CIP1) interacts with protein kinase CK2
    Gotz, C
    Wagner, P
    Issinger, OG
    Montenarh, M
    ONCOGENE, 1996, 13 (02) : 391 - 398
  • [38] The role of cyclin D1 and p21(WAF1/CIP1) in gastric cancer
    Michalaki, V.
    Frangulidis, G.
    Kondi-Pafgiti, A.
    Papakonstandinou, J.
    Vezakis, A.
    Papadimitriou, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S405 - S405
  • [39] p21(WAF1/CIP1) expression in benign and malignant soft tissue tumors
    Pindzola, JA
    Palazzo, JP
    Kovatich, AJ
    Tuma, B
    Nobel, M
    LABORATORY INVESTIGATION, 1997, 76 (01) : 54 - 54
  • [40] Calcium dependent p21 cip1/waf1 stabilizer cyclin I (Ccni)
    Chu, Hsueh-Liang
    Chen, Tzu-Hsuan
    Yeh, Yi-Chen
    Tsai, Chuan-Mei
    Wu, Chang-You
    Svanidze, Anna
    Chang, Chia-Ching
    FASEB JOURNAL, 2008, 22